9 completed, 2 terminated. 11 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 9, Terminated 2 |
| Phase 2 | 2 | Completed 2 |
Follow Peritonitis: new trials by email Literature Review of Peritonitis trials Research Report on Peritonitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis Meropenem 1000 mg, Aztreonam 2000 mg, automated peritoneal dialysis with following long time dwell - Peritoneal Dialysis Associated Peritonitis, Peritoneal Dialysis (PD) | Phase 2 / Phase 3 | Completed | Karl Landsteiner Insitute for Nephrology and Haemato-Oncology | 12 | 2021-08-31 | 2025-08-11 |
| Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites Rifaximin, Placebo - Cirrhosis, Ascites | Phase 3 | Completed | Centre Hospitalier Universitaire de Besancon | 160 | 2018-06-05 | 2025-04-10 |
| Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury Reltecimod 0.5 mg/kg, Placebo - Acute Kidney Injury, Peritonitis | Phase 3 | Terminated | Atox Bio Ltd | 58 | 2018-05-24 | 2021-10-12 |
| A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections Doripenem, Meropenem placebo, Meropenem - Abscess, Intra-Abdominal, Abdominal Abscess | Phase 3 | Terminated | Janssen Research & Development, LLC | 41 | 2010-12-01 | 2014-07-15 |
| Effects of Hemoperfusion With a Polymyxin B Membrane in Peritonitis With Septic Shock standard therapy, hemoperfusion - Peritonitis, Septic Shock | Phase 3 | Completed | Meditor SAS | 243 | 2010-10-01 | 2013-12-18 |
| Protective Effect of N-acetylcysteine Against From Ototoxicity N-acetylcysteine - Hearing Loss, Extreme | Phase 2 / Phase 3 | Completed | TC Erciyes University | 60 | 2010-06-01 | 2011-11-16 |
| SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection duration of antibiotics - Peritonitis | Phase 3 | Completed | University of Virginia | 518 | 2008-09-01 | 2018-05-22 |
| Treatment Duration for Abdominal Tuberculosis RNTCP Category I treatment for 6 months, RNTCP Category I treatment for 9months - Tuberculosis | Phase 3 | Completed | All India Institute of Medical Sciences | 197 | 2008-07-01 | 2015-07-03 |
| Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections tigecycline - Abdominal Abscess | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 200 | 2005-11-01 | 2009-07-07 |
| Doripenem in the Treatment of Complicated Intra-Abdominal Infections doripenem - Bacterial Infections and Mycoses, Appendicitis | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 483 | 2004-03-01 | 2011-06-10 |
| Doripenem in the Treatment of Complicated Intra-Abdominal Infections Doripenem - Bacterial Infections and Mycoses, Appendicitis | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 478 | 2004-03-01 | 2011-06-10 |
Appendicitis (3) · Abdominal Abscess (2) · Bacterial Infections and Mycoses (2) · Cholecystitis (2) · Pancreatitis (2) · Abdomen, Acute (1) · Abdominal Pain (1) · Acute Kidney Injury (1) · Ascites (1) · Community-Acquired Infections (1) · Cross Infection (1) · Deafness (1) · Fibrosis (1) · Ileus (1)
Digestive System Diseases (11) · Peritoneal Diseases (11) · Infections (10) · Intraabdominal Infections (10) · Pathological Conditions, Signs and Symptoms (7) · Pathologic Processes (6) · Cecal Diseases (3) · Gastroenteritis (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Abscess (2) · Biliary Tract Diseases (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2)
Doripenem (3) · Meropenem (2) · AB103 (1) · Acetylcysteine (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Aztreonam (1) · Hemoperfusion (1) · Rifaximin (1) · Saline Solution (1) · Sodium Chloride (1) · Tigecycline (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · All India Institute of Medical Sciences (1) · Atox Bio Ltd (1) · Centre Hospitalier Universitaire de Besancon (1) · Janssen Research & Development, LLC (1) · Karl Landsteiner Insitute for Nephrology and Haemato-Oncology (1) · Meditor SAS (1) · TC Erciyes University (1) · University of Virginia (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
France (3) · United States (3) · Argentina (1) · Austria (1) · Brazil (1) · Canada (1) · Chile (1) · China (1) · Colombia (1) · India (1) · Latvia (1) · Lithuania (1) · Panama (1) · Turkey (Türkiye) (1)
Alexandra Heurgue-Berlot, MD (1) · Alexandre Louvet, MD, PhD (1) · Azra Bihorac, MD (1) · Christophe Bureau, MD, PhD (1) · Claire Francoz, MD (1) · Didier Payen, MD (1) · Dr Govind K Makharia, MD, DM, DNB (1) · Edouard Bardou-Jacquet, MD (1) · Eric Nguyen-Khac, MD, PhD (1) · Fanny Lebosse, MD (1) · Ghassan Riachi, MD (1) · Isabelle Ollivier, MD (1) · Isabelle Rosa-Hezode, MD (1)
PMID 19670912, PMID 20211892, PMID 19036670, PMID 20663130, PMID 25073872, PMID 25862039, PMID 25969531, PMID 25992746, PMID 40653111
2009 (1), R01GM081510 (1)